{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:15:59Z","timestamp":1793754959509,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Patients with impaired renal function using medication that affects glomerular filtration rate are at increased risk of developing acute kidney injury (AKI) leading to hospital admissions. The risk increases during periods of dehydration due to diarrhoea, vomiting or fever (so-called \u201csick days\u201d), or high environmental temperatures (heat wave). This study aims to gain insight into the characteristics and preventability of medication-related admissions for AKI and dehydration in elderly patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective case series study in patients aged\u2009\u2265\u200965\u00a0years with admission for acute kidney injury, dehydration or electrolyte imbalance related to dehydration that was defined as medication-related. General practitioner\u2019s (GP) patient records including medication history and hospital discharge letters were available. For each admission, patient and admission characteristics were collected to review the patient journey. A case-by-case assessment of preventability of hospital admissions was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 75 admissions were included. Most prevalent comorbidities were hypertension, diabetes, and known impaired renal function. Diuretics and RAS-inhibitors were the most prevalent medication combination. Eighty percent of patients experienced non-acute onset of symptoms and 60% had contacted their GP within 2\u00a0weeks prior to admission. Around 40% (<jats:italic>n<\/jats:italic>\u2009=\u200929) of admissions were considered potentially preventable if pharmacotherapy had been timely and adequately adjusted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A substantial proportion of patients admitted with AKI or dehydration experience non-acute onset of symptoms and had contacted their GP within 2\u00a0weeks prior to admission. Timely adjusting of medication in these patients could have potentially prevented a considerable number of admissions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00228-024-03704-7","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T16:02:11Z","timestamp":1717430531000},"page":"1355-1362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics and preventability of medication-related admissions for acute kidney injury and dehydration in elderly patients"],"prefix":"10.1007","volume":"80","author":[{"given":"Tristan","family":"Coppes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankie C. M.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien L. M.","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen S.","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun","family":"van Gelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel L.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"9987","key":"3704_CR1","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/S0140-6736(15)60126-X","volume":"385","author":"RL Mehta","year":"2015","unstructured":"Mehta RL, Cerd\u00e1 J, Burdmann EA, Tonelli M, Garc\u00eda-Garc\u00eda G, Jha V et al (2015) International Society of Nephrology\u2019s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. The Lancet 385(9987):2616\u20132643","journal-title":"The Lancet"},{"issue":"4","key":"3704_CR2","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1681\/ASN.2014121218","volume":"27","author":"ED Siew","year":"2016","unstructured":"Siew ED, Parr SK, Abdel-Kader K, Eden SK, Peterson JF, Bansal N et al (2016) Predictors of recurrent AKI. J Am Soc Nephrol 27(4):1190\u20131200","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3704_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81(5):442\u2013448","journal-title":"Kidney Int"},{"issue":"1","key":"3704_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ (2021) Acute kidney injury. Nat Rev Dis Primers 7(1):52","journal-title":"Nat Rev Dis Primers"},{"key":"3704_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2016.07.011","volume":"167","author":"L Prieto-Garc\u00eda","year":"2016","unstructured":"Prieto-Garc\u00eda L, Pericacho M, Sancho-Mart\u00ednez SM, S\u00e1nchez \u00c1, Mart\u00ednez-Salgado C, L\u00f3pez-Novoa JM et al (2016) Mechanisms of triple whammy acute kidney injury. Pharmacol Ther 167:132\u2013145","journal-title":"Pharmacol Ther"},{"key":"3704_CR6","first-page":"A1548","volume":"154","author":"ND Scherpbier","year":"2010","unstructured":"Scherpbier ND, de Grauw WJ, Wetzels JF, Vervoort GM (2010) Acute renal failure due to RAAS-inhibitors combined with dehydration. Ned Tijdschr Geneeskd 154:A1548","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"6","key":"3704_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.jhh.1001571","volume":"17","author":"C Stirling","year":"2003","unstructured":"Stirling C, Houston J, Robertson S, Boyle J, Allan A, Norrie J et al (2003) Diarrhoea, vomiting and ACE inhibitors:\u2013an important cause of acute renal failure. J Hum Hypertens 17(6):419\u2013423","journal-title":"J Hum Hypertens"},{"issue":"5","key":"3704_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.18773\/austprescr.2017.057","volume":"40","author":"TN Lea-Henry","year":"2017","unstructured":"Lea-Henry TN, Baird-Gunning J, Petzel E, Roberts DM (2017) Medication management on sick days. Aust Prescr 40(5):168\u2013173","journal-title":"Aust Prescr"},{"issue":"1","key":"3704_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12882-019-1636-z","volume":"20","author":"SJ Faber","year":"2019","unstructured":"Faber SJ, Scherpbier ND, Peters HJG, Uijen AA (2019) Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication - an observational study in general practice. BMC Nephrol 20(1):449","journal-title":"BMC Nephrol"},{"key":"3704_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12875-016-0480-5","volume":"17","author":"RL Morris","year":"2016","unstructured":"Morris RL, Ashcroft D, Phipps D, Bower P, O\u2019Donoghue D, Roderick P et al (2016) Preventing acute kidney injury: a qualitative study exploring \u201csick day rules\u201d implementation in primary care. BMC Fam Pract 17:91","journal-title":"BMC Fam Pract"},{"issue":"11","key":"3704_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017241","volume":"7","author":"AM Martindale","year":"2017","unstructured":"Martindale AM, Elvey R, Howard SJ, McCorkindale S, Sinha S, Blakeman T (2017) Understanding the implementation of \u201csick day guidance\u201d to prevent acute kidney injury across a primary care setting in England: a qualitative evaluation. BMJ Open 7(11):e017241","journal-title":"BMJ Open"},{"issue":"9","key":"3704_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100491","volume":"4","author":"KE Watson","year":"2022","unstructured":"Watson KE, Dhaliwal K, McMurtry E, Donald T, Lamont N, Benterud E et al (2022) Sick day medication guidance for people with diabetes, kidney disease, or cardiovascular disease: a systematic scoping review. Kidney Med 4(9):100491","journal-title":"Kidney Med"},{"issue":"4","key":"3704_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012674","volume":"7","author":"P Whiting","year":"2017","unstructured":"Whiting P, Morden A, Tomlinson LA, Caskey F, Blakeman T, Tomson C et al (2017) What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis. BMJ Open 7(4):e012674","journal-title":"BMJ Open"},{"key":"3704_CR14","volume-title":"Chronische Nierschade","author":"WDLK De Grauw","year":"2018","unstructured":"De Grauw WDLK, Schenk P, Scherpbier-De Haan N, Tjin-A-Ton J, Tuut M, Van Balen J (2018) Chronische Nierschade. NHG Standaard. Utrecht: NHG"},{"key":"3704_CR15","unstructured":"Think Kidneys (2018) Sick day guidance in patients at risk of acute kidney injury: a position statement from the Think Kidneys Board. Available from: https:\/\/www.thinkkidneys.nhs.uk\/aki\/wp-content\/uploads\/sites\/2\/2018\/01\/Think-Kidneys-Sick-Day-Guidance-2018.pdf. Accessed 22 Dec 2023"},{"key":"3704_CR16","unstructured":"Canada D (2018) Stay safe when you have diabetes and are sick or at risk of dehydration. Available from: https:\/\/guidelines.diabetes.ca\/docs\/patient-resources\/stay-safe-when-you-have-diabetes-and-sick-or-at-risk-of-dehydration.pdf. Accessed 22 Dec 2023"},{"key":"3704_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12875-015-0296-8","volume":"16","author":"AC Hazen","year":"2015","unstructured":"Hazen AC, Sloeserwij VM, Zwart DL, de Bont AA, Bouvy ML, de Gier JJ et al (2015) Design of the POINT study: pharmacotherapy optimisation through integration of a non-dispensing pharmacist in a primary care team (POINT). BMC Fam Pract 16:76","journal-title":"BMC Fam Pract"},{"issue":"10","key":"3704_CR18","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1111\/bcp.14041","volume":"85","author":"VM Sloeserwij","year":"2019","unstructured":"Sloeserwij VM, Hazen ACM, Zwart DLM, Leendertse AJ, Poldervaart JM, de Bont AA et al (2019) Effects of non-dispensing pharmacists integrated in general practice on medication-related hospitalisations. Br J Clin Pharmacol 85(10):2321\u20132331","journal-title":"Br J Clin Pharmacol"},{"key":"3704_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/IJNRD.S170203","volume":"11","author":"LG Yokota","year":"2018","unstructured":"Yokota LG, Sampaio BM, Rocha EP, Balbi AL, Sousa Prado IR, Ponce D (2018) Acute kidney injury in elderly patients: narrative review on incidence, risk factors, and mortality. Int J Nephrol Renovasc Dis 11:217\u2013224","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"9","key":"3704_CR20","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3390\/jcm12093347","volume":"12","author":"H Duong","year":"2023","unstructured":"Duong H, Tesfaye W, Van C, Sud K (2023) Castelino RL (2023) Hospitalisation due to community-acquired acute kidney injury and the role of medications: a retrospective audit. J Clin Med 12(9):3347","journal-title":"J Clin Med"},{"issue":"14","key":"3704_CR21","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","volume":"360","author":"SF Jencks","year":"2009","unstructured":"Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360(14):1418\u20131428","journal-title":"N Engl J Med"},{"key":"3704_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.567424","volume":"12","author":"EB Uitvlugt","year":"2021","unstructured":"Uitvlugt EB, Janssen MJA, Siegert CEH, Kneepkens EL, van den Bemt BJF, van den Bemt P et al (2021) Medication-related hospital readmissions within 30 days of discharge: prevalence, preventability, type of medication errors and risk factors. Front Pharmacol 12:567424","journal-title":"Front Pharmacol"},{"issue":"10","key":"3704_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00228-023-03548-7","volume":"79","author":"O Krause","year":"2023","unstructured":"Krause O, Ziemann CT, Schulze Westhoff M, Schr\u00f6der S, Krichevsky B, Greten S et al (2023) What do older patients know about their medication? A cross-sectional, interview-based pilot study. Eur J Clin Pharmacol 79(10):1365\u20131374","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"3704_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/bmjebm-2018-110971","volume":"24","author":"T\u00d3 Flatharta","year":"2019","unstructured":"Flatharta T\u00d3, Flynn A, Mulkerrin EC (2019) Heat-related chronic kidney disease mortality in the young and old: differing mechanisms, potentially similar solutions? BMJ Evid Based Med. 24(2):45\u20137","journal-title":"BMJ Evid Based Med."},{"key":"3704_CR25","unstructured":"NHSSCHOTLAND (2018) Medicines Sick Day Rules Card. Available from: https:\/\/ihub.scot\/improvement-programmes\/scottish-patient-safety-programme-spsp\/spsp-medicines\/high-risk-situations-involving-medicines\/medicines-sick-day-rules-card\/. Accessed 6 Jan 2024"},{"issue":"7","key":"3704_CR26","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/s41591-023-02419-z","volume":"29","author":"J Ballester","year":"2023","unstructured":"Ballester J, Quijal-Zamorano M, M\u00e9ndez Turrubiates RF, Pegenaute F, Herrmann FR, Robine JM et al (2023) Heat-related mortality in Europe during the summer of 2022. Nat Med 29(7):1857\u20131866","journal-title":"Nat Med"},{"issue":"5","key":"3704_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/ageing\/afz080","volume":"48","author":"M Brennan","year":"2019","unstructured":"Brennan M, O\u2019Keeffe ST, Mulkerrin EC (2019) Dehydration and renal failure in older persons during heatwaves-predictable, hard to identify but preventable? Age Ageing 48(5):615\u2013618","journal-title":"Age Ageing"},{"issue":"1","key":"3704_CR28","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/s41467-020-16970-7","volume":"11","author":"SE Perkins-Kirkpatrick","year":"2020","unstructured":"Perkins-Kirkpatrick SE, Lewis SC (2020) Increasing trends in regional heatwaves. Nat Commun 11(1):3357","journal-title":"Nat Commun"},{"key":"3704_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.maturitas.2020.05.018","volume":"139","author":"E Rudnicka","year":"2020","unstructured":"Rudnicka E, Napiera\u0142a P, Podfigurna A, M\u0119czekalski B, Smolarczyk R, Grymowicz M (2020) The World Health Organization (WHO) approach to healthy ageing. Maturitas 139:6\u201311","journal-title":"Maturitas"},{"issue":"1","key":"3704_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","volume":"22","author":"CJ Bailey","year":"2022","unstructured":"Bailey CJ, Day C, Bellary S (2022) Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease. Curr Diab Rep 22(1):39\u201352","journal-title":"Curr Diab Rep"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03704-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T07:03:54Z","timestamp":1722927834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03704-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3704"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03704-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"3 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethical Committee of the University Medical Center Utrecht waived the formal medical-ethical assessment (METC protocol number 13-432C). This decision was made because the intervention of the initial study was performed on a healthcare setting level rather than on an individual patient level. The collected data was routine healthcare data on a population level and all data was anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}